Acemannan Research Reference
This document compiles the primary research on acemannan, the active polysaccharide in aloe vera inner gel, and is organized by category. Each study includes a brief explanation of what the researchers found and why it matters. All citations are hyperlinked for verification. This is a working reference, not a clinical guide.
Compiled by The Ace Edit | See Disclaimer
TABLE OF CONTENTS
1. Macrophage Activation & Immune Signaling
2. Pattern Recognition & Innate Immune Activation
4. Dendritic Cells & Adaptive Immunity
6. Natural Killer Cell Activity
8. HIV & Clinical Immune Outcomes
9. Immune Homeostasis & Modulation
10. Wound Healing & Tissue Repair
11. Stem Cell Proliferation & Hematopoiesis
12. Gut Barrier & Mucosal Health
13. Phagocytosis & Candida Killing
14. Cancer Research & Oncology
15. Alzheimer's Disease & Cognitive Function
16. Diabetes, Metabolism & Metabolic Syndrome
23. Pediatric & Neurodevelopmental Research
26. Broad PubMed Search Strings for Additional Research
Zhang L, Tizard IR — Activation of a Mouse Macrophage Cell Line by Acemannan (1996)
Immunopharmacology. 35(2):119-128. https://pubmed.ncbi.nlm.nih.gov/8891103/
What this means: Macrophages are the immune system's first responders — they patrol the body looking for debris, pathogens, and damaged cells. This study showed that acemannan directly activates macrophages. When acemannan binds to receptors on the macrophage surface, those cells wake up and start working more aggressively. The researchers used a standard mouse macrophage cell line to confirm this was a direct effect of acemannan itself, not something else in the aloe plant.
Schepetkin IA, Quinn MT — Botanical Polysaccharides: Macrophage Immunomodulation and Therapeutic Potential (2006)
International Immunopharmacology. 6(3):317-333. https://pubmed.ncbi.nlm.nih.gov/16428067/
What this means: This review puts acemannan in context. Plant-derived polysaccharides — complex sugar chains — have a documented history of activating macrophages through specific receptor binding, not random stimulation. The immune system has dedicated docking sites designed to recognize polysaccharides, which explains why acemannan gets a predictable, measured response rather than chaotic immune activation.
Marshall et al. — Acemannan and Cytokine Induction: IL-1, IL-6, TNF-alpha, Interferon Production
PubMed search: → Search link
What this means: Cytokines are the chemical signals the immune system uses to coordinate its response. IL-1, IL-6, TNF-alpha, and interferon tell different parts of the immune system what to do. This research showed that acemannan triggers macrophages to release these signaling molecules — giving them a reason to start broadcasting. The downstream effect is a coordinated immune response, not just localized activity.
Li et al. — Acemannan Enhances Mitochondrial Metabolism via PI3K/Akt/GSK-3β Signaling, Promoting M2 Macrophage Polarization
PubMed search: → Search link
What this means: This study looked at acemannan's effect on macrophage polarization — specifically the shift toward M2 macrophages, which are associated with tissue repair and resolution of inflammation rather than aggressive pro-inflammatory activity. Acemannan activated mitochondrial metabolism through the PI3K/Akt/GSK-3β signaling pathway, reducing pro-inflammatory cytokines TNF-α, IL-6, IL-8, and IL-1β while promoting the repair-oriented M2 state. This is relevant to understanding how acemannan modulates rather than simply amplifies immune activity.
Janeway CA Jr. — Approaching the Asymptote? Evolution and Revolution in Immunology (1989)
Cold Spring Harbor Symposia on Quantitative Biology. https://pubmed.ncbi.nlm.nih.gov/2643058/
What this means: This foundational paper introduced the concept that the immune system has ancient recognition systems designed to detect specific molecular patterns. Acemannan works through these same systems. Understanding this paper helps explain why a plant compound can interact so precisely with human immune cells. The body's pattern recognition machinery evolved to detect polysaccharides because they appear on the surfaces of bacteria and fungi.
Medzhitov R, Janeway CA Jr. — Innate Immune Recognition: Mechanisms and Pathways (2000)
Immunological Reviews. 173:89-97. https://pubmed.ncbi.nlm.nih.gov/10719670/
What this means: This paper went deeper into how pattern recognition works at the receptor level. The innate immune system — the older, faster branch — uses Toll-like receptors and other sensors to detect specific molecular shapes. Acemannan fits into this system because its structure is recognized as a microbial-associated pattern. The immune system responds to it the same way it would respond to early signs of infection, priming the whole cascade without causing inflammation from an actual pathogen.
Taylor PR et al. — The Mannose Receptor: Linking Homeostasis and Immunity Through Sugar Recognition (2005)
Trends in Immunology. 26(2):104-110. https://pubmed.ncbi.nlm.nih.gov/15668123/
What this means: The mannose receptor is the specific docking site on macrophages that recognizes acemannan. It evolved to detect mannose-containing sugars — which appear on bacteria, fungi, and certain parasites. Acemannan is an acetylated polymannose, built from mannose units. When acemannan binds to this receptor, it triggers phagocytosis and immune signaling. This paper established the receptor's role in both pathogen clearance and homeostasis — keeping the immune system calibrated.
Pugh N et al. — Aloe Vera Polysaccharides Stimulate Cytokine Production (2001)
Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/11262050/
What this means: This study confirmed that the polysaccharide fraction of aloe vera — acemannan — is the part responsible for stimulating cytokine production, not the anthraquinones or other plant compounds. The researchers isolated different fractions and tested them separately. The polysaccharide fraction consistently produced cytokine stimulation while other fractions did not. This confirms that inner leaf acemannan extracts carry the active immune component.
Dinarello CA — Proinflammatory Cytokines (2000)
Chest. 118(2):503-508. https://pubmed.ncbi.nlm.nih.gov/10936147/
What this means: This reference paper explains what proinflammatory cytokines actually do — their role in coordinating immune defense, fever production, acute phase responses, and tissue repair. Reading this alongside the acemannan research clarifies that when acemannan triggers cytokine release, it initiates a controlled, purposeful immune response — the kind the body runs when it encounters a threat — not random inflammation.
Turner MD et al. — Cytokines and Chemokines: At the Crossroads of Cell Signalling and Inflammatory Disease (2014)
Biochimica et Biophysica Acta. 1843(11):2563-2582. https://pubmed.ncbi.nlm.nih.gov/24892271/
What this means: This comprehensive review explains how cytokines and chemokines work together to direct immune traffic. Chemokines recruit specific immune cells to specific locations. Cytokines tell those cells what to do when they arrive. Acemannan works upstream in this system — by triggering cytokine release from macrophages, it sets the entire cascade in motion.
Lee JK et al. — Acemannan Purified from Aloe Vera Induces Phenotypic and Functional Maturation of Immature Dendritic Cells (2001)
International Immunopharmacology. 1(7):1275-1284. https://pubmed.ncbi.nlm.nih.gov/11460308/
What this means: Dendritic cells are the bridge between innate and adaptive immunity. They patrol tissue, collect samples, and travel to the lymph nodes to present those samples to T-cells. When immature, they collect but don't communicate well. This study showed that acemannan causes dendritic cells to mature — developing the surface markers and signaling capacity needed to activate T-cells effectively. Acemannan prepares the immune system's messenger cells to do their job.
Banchereau J, Steinman RM — Dendritic Cells and the Control of Immunity (1998)
Nature. 392(6673):245-252. https://pubmed.ncbi.nlm.nih.gov/9521319/
What this means: The foundational paper on dendritic cell biology. It established that dendritic cells are the primary regulators of adaptive immunity — they determine whether the T-cell response is activated, suppressed, or tolerant. Acemannan does not work on T-cells directly. It works upstream, on the dendritic cells that instruct the T-cells.
Iwasaki A, Medzhitov R — Control of Adaptive Immunity by the Innate Immune System (2015)
Nature Immunology. 16(4):343-353. https://pubmed.ncbi.nlm.nih.gov/25789684/
What this means: This review explains how the fast, non-specific innate immune system controls the slower, precise adaptive immune system. Acemannan activates innate immunity first — the macrophages, the pattern recognition — and that activation shapes the adaptive response that follows. This is why activating the innate system matters for whole-body immune coordination, not just immediate defense.
Zhu J, Yamane H, Paul WE — Differentiation of Effector CD4 T Cell Populations (2010)
Annual Review of Immunology. 28:445-489. https://pubmed.ncbi.nlm.nih.gov/20192806/
What this means: T-cells are the specialized soldiers of the immune system. Different types do different things — some kill infected cells directly, some coordinate other immune cells, some regulate the response so it doesn't overshoot. This paper explains the differentiation process that decides which kind a naive T-cell becomes. Acemannan, through its effects on macrophages and dendritic cells, influences what signals those cells send to naive T-cells — which shapes the type of T-cell response that develops.
Womble D, Helderman JH — The Impact of Acemannan on the Generation and Function of Cytotoxic T-Lymphocytes (1992)
Immunopharmacology and Immunotoxicology. 14(1-2):63-77. https://pubmed.ncbi.nlm.nih.gov/1597661/
What this means: This study measured acemannan's direct effect on cytotoxic T-cell generation — the immune cells that kill infected and tumor cells. At the lowest test dose, acemannan nearly doubled T-cell killing capacity. At the highest dose, it produced a 3.5-fold increase. Adding acemannan after the allostimulation process increased killing capacity by nearly 50%. Acemannan itself was not directly toxic to target cells. The effect was entirely immune-mediated.
Vivier E et al. — Functions of Natural Killer Cells (2008)
Nature Immunology. https://pubmed.ncbi.nlm.nih.gov/18641647/
What this means: Natural killer cells are innate immune cells that can detect and destroy abnormal cells — virally infected cells, cancer cells — without prior exposure or T-cell instruction. This paper establishes what NK cells do and how they recognize their targets. It provides the biological background for understanding why acemannan's effect on NK cells matters, particularly in the context of viral infection and cancer surveillance.
Busbee et al. — NK Cell Cytotoxicity and Tumor/Viral Targeting with Acemannan
PubMed search: → Search link
What this means: This research showed that acemannan enhances NK cell activity — their capacity to identify and destroy tumor cells and virally infected cells. NK cells work fast, before the adaptive immune system has time to mount a targeted response. Acemannan's ability to prime NK cells means earlier detection and destruction of abnormal cells.
McAnalley BH — In Vivo and In Vitro Antiviral Activity of Acemannan (1989)
Molecular Biotherapy. https://pubmed.ncbi.nlm.nih.gov/2609879/
What this means: Early foundational work establishing that acemannan has antiviral activity in living systems, not just cell cultures. Antiviral effects have since been documented against influenza H1N1, herpes simplex virus-1, feline AIDS, HIV-1, and measles. The mechanism appears to involve both direct interference with viral entry and enhanced immune cell activity against infected cells.
Song EJ et al. — Adjuvanticity of Processed Aloe Vera Gel for Influenza Vaccination in Mice (2020)
Immune Network. 20(4):e31. → Search link
What this means: An adjuvant is something added to a vaccine to boost the immune response to it. This study tested whether processed aloe vera gel could serve as an adjuvant for an influenza vaccine in mice. The aloe-treated group showed an enhanced immune response. This suggests acemannan may help the immune system respond more effectively to immune challenges. The mechanism aligns with acemannan's macrophage and dendritic cell activation effects.
McDaniel et al. — CD4 Counts, Viral Load, and Immune Restoration with Acemannan
PubMed search: → Search link
What this means: CD4 T-cells are the primary immune cells targeted by HIV. Lower CD4 counts mean a compromised immune system. This research examined whether acemannan supplementation affected CD4 counts and viral load in HIV patients. The findings supported the idea that acemannan's immune-activating effects are clinically meaningful — not just laboratory observations. The research was conducted at a time when effective antiviral options were limited, making immune support particularly significant.
Womble D, Helderman JH — Enhancement of Allo-Responsiveness of Human Lymphocytes by Acemannan (1988)
International Journal of Immunopharmacology. https://pubmed.ncbi.nlm.nih.gov/2975271/
What this means: This study looked at how acemannan affects human lymphocytes — the white blood cells that include T-cells and B-cells. The researchers found that acemannan enhanced allo-responsiveness, meaning lymphocytes became more reactive to foreign cells. This was an early human cell study confirming that the immune effects seen in animal models translated to human immune cells.
Im SA et al. — In Vivo Evidence of the Immunomodulatory Activity of Orally Administered Aloe Vera Gel (2010)
Archives of Pharmacal Research. 33(3):451-456. https://pubmed.ncbi.nlm.nih.gov/20361311/
What this means: A key question about acemannan is whether oral administration actually does anything — or whether the compound gets broken down in the gut before it can work. This study provided direct in vivo evidence that orally administered aloe vera gel modulates immune activity in living animals. It also documented increased IL-10 — the anti-inflammatory cytokine that helps keep the immune response balanced and directly suppresses mast cell degranulation. This matters for anyone asking whether drinking acemannan is meaningfully different from applying it topically.
Im SA et al. — Processed Aloe Vera Gel Ameliorates Cyclophosphamide-Induced Immunotoxicity (2014)
International Journal of Molecular Sciences. 15(11):19342-19354. https://pubmed.ncbi.nlm.nih.gov/25347273/
What this means: Cyclophosphamide is a chemotherapy drug that suppresses the immune system as a side effect. This study tested whether processed aloe vera gel could reduce that immune suppression. The aloe-treated group showed improved immune markers compared to controls receiving cyclophosphamide alone. This demonstrates acemannan's capacity to support immune recovery in a context of significant immune stress — not just baseline immune enhancement.
Im SA et al. — Identification of Optimal Molecular Size of Modified Aloe Polysaccharides with Maximum Immunomodulatory Activity (2005)
International Immunopharmacology. 5(2):271-279. → Search link
What this means: Not all acemannan is equal. This study found that the immune-activating effect of aloe polysaccharides depends on molecular size — there is an optimal size range. Too small and the effect diminishes; too large and bioavailability suffers. This is why processing and stabilization methods matter. Raw aloe gel degrades quickly. Stabilized extracts that preserve the appropriate molecular weight have significantly better immune activity than degraded or improperly processed products.
Bai Y et al. — A New Biomaterial Derived from Aloe Vera: Acemannan from Basic Studies to Clinical Application (2023)
Pharmaceutics. 15(7):1913. https://pubmed.ncbi.nlm.nih.gov/37514099/
What this means: This 2023 comprehensive review covers acemannan's full clinical application range including wound healing, bone regeneration, dental pulp therapy, cancer models, and immune modulation. The cancer section documents acemannan's antitumor activity across multiple models, noting caspase-3-mediated apoptosis induction, tumor volume reduction, and cytotoxic T-lymphocyte generation through macrophage-mediated immune activation. Also covers acemannan as a biomaterial scaffold for tissue engineering and regenerative medicine.
Im SA et al. — Immuno-Modulating Properties of Aloe Vera and Its Fractions
Journal of Pathology and Translational Medicine. https://jpathology.com/index.php/OJS/article/download/698/414/1512
What this means: This review covers T-cell modulation, complement system activation, cytokine regulation, and nitric oxide synthesis as they relate to multiple conditions including MS, hyperthyroidism, psoriasis, and lichen planus. It examines different fractions of aloe vera and their distinct immune roles, which helps clarify which effects are attributable to acemannan specifically versus other plant compounds.
Medzhitov R — Origin and Physiological Roles of Inflammation (2008)
Nature. 454(7203):428-435. https://pubmed.ncbi.nlm.nih.gov/18650913/
What this means: Inflammation has developed a reputation as something to suppress. This paper reframes it: inflammation is a designed physiological response that initiates repair, clears pathogens, and eventually resolves. The problem is not inflammation itself but dysregulated inflammation that does not resolve properly. Acemannan's role in triggering controlled cytokine signaling fits within this framework — it initiates the kind of immune activity that leads to resolution, not the chronic low-grade inflammation underlying most modern disease.
Tracey KJ — The Inflammatory Reflex (2002)
Nature. 420(6917):853-859. https://pubmed.ncbi.nlm.nih.gov/12490958/
What this means: This paper introduced the concept of a neural circuit — the vagus nerve — that actively controls inflammation in real time. The inflammatory reflex means the nervous system and the immune system are in constant communication. Immune function is not isolated. It is integrated with the nervous system, the gut, and the brain. Compounds that support macrophage balance, like acemannan, may interact with this broader system rather than acting on immune cells alone.
Sadgrove NJ, Simmonds MSJ — Pharmacodynamics of Aloe Vera and Acemannan in Therapeutic Applications for Skin, Digestion, and Immunomodulation (2021)
Phytotherapy Research. 35(12):6572-6584. https://pubmed.ncbi.nlm.nih.gov/34427371/
What this means: This review examines how acemannan actually works in the body — its pharmacodynamics — across skin, digestion, and immune modulation. It covers the prebiotic mechanism, short-chain fatty acid production, GLP-1 stimulation, and acemannan's role in insulin sensitivity. It also addresses the gut barrier effects and systemic immune signaling that result from oral acemannan intake. Mechanistically rich and useful for understanding the why behind the clinical findings.
Tizard IR et al. — Effects of Acemannan on Wound Healing and Immune Function (1994)
Journal of the American Animal Hospital Association. https://pubmed.ncbi.nlm.nih.gov/8070599/
What this means: This study tested acemannan's effects on wound healing and immune function simultaneously. Acemannan increased the rate of wound closure, stimulated new blood vessel formation in healing tissue, and enhanced immune markers at the same time. The overlap makes sense — macrophages are critical to both immune defense and wound repair. Acemannan appears to support both functions through the same mechanism of macrophage activation.
Davis RH et al. — Anti-Inflammatory and Wound Healing Activity of a Growth Substance in Aloe Vera (1994)
Journal of the American Podiatric Medical Association. → Search link
What this means: This research identified a growth-promoting substance in aloe vera that contributes to wound healing. The compound reduced inflammation at wound sites while simultaneously promoting tissue repair. The combination — reduced inflammation plus accelerated healing — reflects acemannan's modulating role rather than simple stimulation.
Davis RH et al. — Wound Healing: Oral and Topical Activity of Aloe Vera (1989)
Journal of the American Podiatric Medical Association. → Search link
What this means: This earlier Davis study examined both oral and topical aloe vera administration for wound healing — an important distinction. Both routes produced wound healing activity, which supports the idea that orally consumed acemannan has systemic effects that reach peripheral tissue. The 1989 and 1994 Davis papers together establish a consistent pattern of wound healing activity across routes of administration.
Chithra P et al. — Influence of Aloe Vera on Collagen Characteristics in Healing Dermal Wounds (1998)
Molecular and Cellular Biochemistry. → Search link
What this means: This study examined aloe vera's effect on collagen — the structural protein that holds repaired tissue together. Aloe-treated wounds showed improved collagen crosslinking, higher collagen content, and better tensile strength compared to controls. Collagen quality determines whether healed tissue is strong or weak. This confirmed that acemannan's wound healing effects extend to the structural quality of the tissue formed, not just the speed of closure.
Chou MH et al. — Potential of Methacrylated Acemannan for Antioxidant, Cell Proliferation, and Cell Migration-Inducing Activities In Vitro (2023)
BMC Complementary Medicine and Therapies. 23:204. https://doi.org/10.1186/s12906-023-04022-8
What this means: This 2023 study examined a modified form of acemannan and its effect on cell behavior relevant to healing. Acemannan promoted antioxidant activity, stimulated cell proliferation, and encouraged cell migration — the three basic processes required for tissue repair. Cells need to multiply to replace what was lost, migrate to the wound site, and manage oxidative stress in the process. Acemannan supported all three simultaneously.
Peng SY et al. — The Effect of Aloe Polysaccharide on Hematopoiesis in Irradiated Mice (1991)
Journal of Radiation Research. → Search link
What this means: Hematopoiesis is the process by which stem cells in bone marrow produce blood cells — including immune cells. Radiation suppresses this process significantly. This study showed that aloe polysaccharides helped restore hematopoiesis in mice whose bone marrow had been compromised by radiation. Immune cells have to be made before they can be deployed. Acemannan's role in bone marrow activity means it may support immune function at the level of immune cell production, not just activation of existing cells.
Related: Acemannan has been shown to bind to TLR4 and protect against radiation-induced injury by stimulating macrophage-dependent hematopoiesis. Roberts et al. documented acemannan-induced secretion of TNF and IL-1, increasing hematopoietic progenitor activity in myelosuppressed mice.
PubMed search: → Search link
Langmead L et al. — Randomized, Double-Blind, Placebo-Controlled Trial of Aloe Vera Gel for Ulcerative Colitis (2004)
Alimentary Pharmacology and Therapeutics. 19(7):739-747. → Search link
What this means: A clinical trial — human subjects, double-blind, placebo-controlled — testing aloe vera gel in active ulcerative colitis. The aloe group showed significantly greater response rates and remission rates compared to placebo, with reduced disease activity scores and histological improvement in the gut lining. Ulcerative colitis involves both immune dysregulation and impaired gut barrier integrity. Acemannan's ability to modulate both makes it mechanistically relevant to this condition.
Tanaka M et al. — Effects of Aloe Vera on Gastric Mucosal Injury (2006)
Journal of Ethnopharmacology. → Search link
What this means: This study looked at how aloe vera components affect the stomach lining's integrity and healing after injury. Aloe vera reduced mucosal damage and accelerated healing of gastric lesions through both anti-inflammatory activity and direct tissue support. The gut lining is the primary interface between the immune system and the outside world. Supporting its integrity affects everything downstream.
Gullón B et al. — Prebiotic Activity of Aloe Mannans and Short-Chain Fatty Acid Production (2015)
Phytotherapy Research. → Search link
What this means: This study showed that acemannan functions as a prebiotic — it feeds beneficial gut bacteria that produce short-chain fatty acids like butyrate. Short-chain fatty acids regulate intestinal permeability, reduce inflammation, activate GLP-1 (relevant to blood sugar regulation), and communicate directly with immune cells in the gut lining. Acemannan feeding the microbiome is a separate mechanism from its direct immune receptor binding — and both happen simultaneously.
Na et al. — Oral Treatment with Aloe Polysaccharide Ameliorates Ovalbumin-Induced Atopic Dermatitis by Restoring Tight Junctions in Skin (2020)
Scandinavian Journal of Immunology. https://pubmed.ncbi.nlm.nih.gov/31794090/
What this means: Oral aloe polysaccharides suppressed allergic skin disease by improving gut tight junction integrity — the seals between intestinal cells. When tight junctions are compromised, immune activation in the gut can drive systemic inflammation that shows up as skin conditions. The aloe group showed reduced IgE levels, less epidermal thickness, and partially restored tight junction gene expression. Oral intake producing skin-level results through gut-immune interaction is a key finding for anyone approaching skin conditions from a terrain perspective.
Karaca K et al. — Upregulation of Phagocytosis and Candidicidal Activity of Macrophages Exposed to Acemannan (1997)
PubMed. https://pubmed.ncbi.nlm.nih.gov/9278177/
What this means: Phagocytosis is the process by which macrophages engulf and destroy pathogens and cellular debris. This study showed that acemannan increases phagocytic activity and specifically improves macrophages' ability to kill Candida — the yeast involved in opportunistic fungal infections. Acemannan does not kill Candida directly. It makes the macrophages more effective at doing so.
Peng SY et al. — Decreased Mortality of Norman Murine Sarcoma in Mice Treated with Acemannan (1991)
Molecular Biotherapy. 3(2):79-87. https://pubmed.ncbi.nlm.nih.gov/1910624/
What this means: One of the foundational cancer studies. Approximately 40% of mice treated with acemannan at the time of tumor implantation survived. Tumors showed vascular congestion, immune cell infiltration, central necrosis, and hemorrhage — signs that the immune system was mounting an attack on the tumor itself. Acemannan-stimulated macrophages produced IL-1 and TNF, which initiated the immune response that drove tumor regression. Acemannan was not directly cytotoxic — it coordinated an immune attack.
Harris C et al. — Efficacy of Acemannan in Treatment of Canine and Feline Spontaneous Neoplasms (1991)
Molecular Biotherapy. 3(4):207-213. https://pubmed.ncbi.nlm.nih.gov/1768373/
What this means: 43 dogs and cats with spontaneous tumors — naturally occurring, not implanted — were treated with acemannan. 26 showed histopathological evidence of immune attack on the tumor. 12 showed obvious clinical improvement including tumor shrinkage, necrosis, or prolonged survival. 5 of 7 fibrosarcoma cases responded. The mechanism was macrophage activation and the resulting release of TNF, IL-1, and interferon — the same cytokines documented in the macrophage activation research.
King GK et al. — The Effect of Acemannan Immunostimulant in Combination with Surgery and Radiation Therapy on Spontaneous Canine and Feline Fibrosarcomas (1995)
Journal of the American Animal Hospital Association. 31(5):439-447. https://pubmed.ncbi.nlm.nih.gov/8542364/
What this means: 8 dogs and 5 cats with confirmed fibrosarcomas — all with recurrent disease or poor prognosis — were treated with weekly acemannan combined with surgery and radiation. Tumor shrinkage occurred in 4 of 12 measurable animals. 7 of 13 remained alive and tumor-free with a median survival of 372 days. This study is referenced in the original U.S. medical use patent for acemannan. It represents the strongest clinical veterinary oncology data.
Shih PC et al. — The Aloe Vera Acemannan Polysaccharides Inhibit Phthalate-Induced Cell Viability, Metastasis, and Stemness in Colorectal Cancer Cells (2024)
Ecotoxicology and Environmental Safety. 288:117351. https://pubmed.ncbi.nlm.nih.gov/39561564/
What this means: This 2024 study looked at colorectal cancer cells exposed to phthalates — common plastic-based environmental toxins. Acemannan inhibited proliferation, migration, invasion, and cancer stemness. Tumor volume was reduced in mouse models and caspase-3 expression — a marker of programmed cell death — was increased in the acemannan group. The combination of blocking growth, preventing spread, and triggering self-destruction makes this a mechanistically complete finding.
Additional cancer mechanism search links:
Acemannan + macrophage + tumor necrosis factor: → Search link
Acemannan + cytotoxic T-lymphocyte: → Search link
Acemannan + NK cell + tumor: → Search link
Acemannan + apoptosis + caspase: → Search link
Lewis JE, McDaniel HR et al. — The Effect of an Aloe Polymannose Multinutrient Complex on Cognitive and Immune Functioning in Alzheimer's Disease (2013)
Journal of Alzheimer's Disease. 33(2):393-406. https://pubmed.ncbi.nlm.nih.gov/22976077/
What this means: This clinical study used an acemannan-based multinutrient complex with Alzheimer's patients and measured both cognitive function and immune markers over time. The supplemented group showed improvements across multiple cognitive domains. The immune data showed meaningful changes in immune cell populations and cytokine profiles. The brain and the immune system are deeply connected — neuroinflammation is a core feature of Alzheimer's progression. Supporting immune balance may influence neurological outcomes through that connection.
Martin A et al. — The Effect of Dietary Supplementation on Brain-Derived Neurotrophic Factor and Cognitive Functioning in Alzheimer's Dementia (2017)
Journal of Clinical and Translational Research. https://pubmed.ncbi.nlm.nih.gov/30895275/
What this means: BDNF — brain-derived neurotrophic factor — supports the survival and growth of neurons. Low BDNF is associated with cognitive decline. This study found that the aloe polymannose supplement increased BDNF levels in Alzheimer's patients, and higher BDNF correlated with improved cognitive performance. The connection between immune modulation and neurotrophic support is not fully mapped, but acemannan's ability to influence both makes it mechanistically interesting for brain health.
Stillman J, Martin A et al. — Relationship Between BDNF and Immune Function During Dietary Supplement Treatment of Elderly with Alzheimer's Dementia (2020)
Journal of Clinical and Translational Research. https://pubmed.ncbi.nlm.nih.gov/32377581/
What this means: This follow-up examined the relationship between BDNF improvements and immune function changes in the same patient population. The researchers found that immune changes and BDNF changes were correlated — suggesting acemannan's immune effects and cognitive effects may be mechanistically linked rather than occurring in parallel. This points toward the gut-immune-brain axis as a coherent system where supporting one component influences the others.
Lewis JE et al. — Characterization of the Th1/Th2 Ratio in Moderate-Severe Alzheimer's Disease Patients and Its Response to an Aloe Polymannose-Based Dietary Supplement (2023)
Journal of Alzheimer's Disease. 96(4):1723-1737. https://pubmed.ncbi.nlm.nih.gov/38007658/
What this means: The Th1/Th2 balance refers to which type of immune response predominates. Alzheimer's disease is associated with a skewed Th1/Th2 ratio. This 2023 study showed that the aloe polymannose supplement influenced this ratio toward better balance in moderate-to-severe Alzheimer's patients. Immune balance in the brain is relevant because neuroinflammation drives disease progression. Restoring that balance may slow the process.
Devaraj S et al. — Effects of Aloe Vera Supplementation in Subjects with Prediabetes/Metabolic Syndrome (2013)
Metabolism: Clinical and Experimental. 11(1):35-40. https://pubmed.ncbi.nlm.nih.gov/23035844/
What this means: This double-blind, placebo-controlled pilot study enrolled 45 subjects with prediabetes or metabolic syndrome. The aloe inner leaf gel powder group showed significant reductions in total cholesterol, LDL, glucose, and fructosamine. The standardized aloe group showed significant reductions in HbA1c, fasting glucose, insulin, insulin resistance markers, and oxidative stress. Both forms produced measurable improvements across multiple metabolic markers.
Acemannan RCT — Postprandial Lipids and Glucose (2024)
Journal of Functional Foods. https://www.sciencedirect.com/science/article/pii/S1756464624000173
What this means: The most recent and specific acemannan-focused metabolic study. 16 overweight or obese men received 1 gram of acemannan added to aloe vera juice before a high-fat meal. The acemannan group had significantly reduced postprandial triglycerides and free fatty acids, suppressed postprandial glucose and TNF-alpha at the six-hour mark, enhanced antioxidant capacity, and reported increased fullness with decreased hunger. Elevated postprandial triglycerides are an independent cardiovascular risk factor — this finding is clinically meaningful.
Shakib Z et al. — Aloe Vera as an Herbal Medicine in the Treatment of Metabolic Syndrome: A Review (2019)
Phytotherapy Research. 33(10):2649-2660. https://pubmed.ncbi.nlm.nih.gov/31456283/
What this means: This review consolidated research on aloe vera and metabolic syndrome — the cluster of hyperglycemia, dyslipidemia, hypertension, and obesity that precedes type 2 diabetes and cardiovascular disease. Documented mechanisms include pancreatic lipase inhibition, suppression of fat cell formation genes, AMPK activation, and improved insulin sensitivity at the receptor level. These are not additive effects of a single compound — acemannan is influencing multiple metabolic pathways.
Aloe barbadensis Mill. Formulation Restores Lipid Profile in Letrozole-Induced PCOS Rat Model (2012)
Journal of Human Reproductive Sciences. https://pubmed.ncbi.nlm.nih.gov/22518083/
What this means: This study used a PCOS animal model induced by letrozole — a standard method that produces the hormonal and metabolic features of polycystic ovarian syndrome. Aloe treatment significantly reduced triglycerides and LDL, increased HDL, and reversed abnormal estrous cyclicity, glucose intolerance, and lipid enzyme abnormalities. PCOS involves both hormonal disruption and metabolic dysregulation that are deeply intertwined. The fact that aloe treatment affected both domains simultaneously is mechanistically coherent with its systemic effects.
Hypoglycemic and Hypolipidemic Effects of Aloe Vera Extract Preparations: A Review
PubMed. https://pubmed.ncbi.nlm.nih.gov/26666199/
What this means: A comprehensive review of carbohydrate and lipid metabolism mechanisms across animal and human studies. Covers how aloe vera extracts — with acemannan identified as the primary active compound — influence blood glucose regulation, insulin sensitivity, and lipid profiles. Useful as a consolidated reference for the metabolic research base.
Aloe Vera in Diabetic Dyslipidemia: Improving Blood Glucose and Lipoprotein Levels in Pre-Clinical and Clinical Studies (2022)
PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9732414/
What this means: This 2022 review documents acemannan as the primary active compound responsible for both anti-diabetic and lipid-modulating effects in aloe vera. It covers pre-clinical and clinical evidence together, making it useful for mapping where the animal data has and has not been replicated in humans.
Anthraquinones and Aloe Vera Extracts as Potential Modulators of Inflammaging Mechanisms: A Translational Approach from Autoimmune to Onco-Hematological Diseases (2025)
Molecules. 30(6):1251. https://www.mdpi.com/1420-3049/30/6/1251
What this means: This 2025 comprehensive review covers aloe vera and acemannan across multiple autoimmune conditions including rheumatoid arthritis, lupus nephritis, and autoimmune thyroiditis. Documents aloe's ability to regulate hormone balance, autoantibody production, and cytokine signaling including IL-1β, TNF-α, and IFN-γ. Identifies modulation of MAPK and PI3K/AKT inflammatory pathways and notes capacity to reduce C-reactive protein and modulate T-cell activity in rheumatoid arthritis.
Therapeutic Approach by Aloe Vera in Experimental Model of Multiple Sclerosis (2010)
Immunopharmacology and Immunotoxicology. 32(3):410-415. https://pubmed.ncbi.nlm.nih.gov/20233107/
What this means: This study used the standard MS animal model — experimental autoimmune encephalomyelitis in C57BL/6 mice — which involves demyelination and axonal loss similar to human MS. Oral aloe vera at 120mg/kg/day was tested for therapeutic effect on this recognized research model for MS interventions, evaluating whether aloe modulated the autoimmune process driving the neurological damage.
Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis: Aloe Vera and Citrus Bergamia as Potential Candidates for Intestinal Health (2022)
PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9269320/
What this means: This review covers the gut microbiota's role in MS pathogenesis and examines acemannan's contribution through the gut-brain axis. Acemannan functions as a prebiotic, feeding beneficial gut bacteria that produce short-chain fatty acids which communicate with immune cells in the gut lining, connecting to systemic immunity and the nervous system. The microbiota-brain communication pathway is increasingly understood as relevant to autoimmune neurological conditions.
McDaniel HR et al. — Decreased Occurrence of Infection in MS Patients Treated with 12 Months of a Polysaccharide-Based Multinutrient Dietary Supplement
Scholar search: → Search link
What this means: MS patients have elevated infection risk due to both the disease process and the immunosuppressive medications used to manage it. This study tracked infection rates in MS patients receiving a polysaccharide-based supplement over 12 months. The supplemented group showed decreased infection occurrence compared to baseline and control groups. Acemannan's immune-supporting effects appear to function even in a complex autoimmune context — supporting defense without exacerbating the autoimmune process.
Comparing the Therapeutic Effects of Aloe Vera and Olive Oil Combination Cream Versus Topical Betamethasone for Atopic Dermatitis: A Randomized Double-Blind Clinical Trial (2020)
PubMed. https://pubmed.ncbi.nlm.nih.gov/33072415/
What this means: Betamethasone is a corticosteroid commonly prescribed for atopic dermatitis. This randomized trial compared the aloe and olive oil combination directly against betamethasone. After 6 weeks, the aloe combination was superior for disease severity scores, quality of life measures, and eosinophil count — a marker of allergic inflammation. A natural topical outperforming a pharmaceutical corticosteroid in a double-blind trial is a finding worth examining carefully.
Exploring Acemannan-Loaded Nanogel Formulation for the Treatment of IMQ-Induced Psoriasis-Like Inflammation (2025)
International Immunopharmacology. 2025. https://www.sciencedirect.com/science/article/abs/pii/S1567576925000530
What this means: This 2025 study used an acemannan-loaded nanogel in the imiquimod-induced psoriasis mouse model. Results showed significant reduction in skin redness, scaling, inflammation, and lesion size. Skin moisture improved. Pro-inflammatory cytokines and nitric oxide were reduced. Histopathological analysis confirmed skin structure improvement. Nanogel delivery improved acemannan penetration and sustained release at the application site.
Acemannan-Loaded Nanogel for IMQ-Induced Psoriasis-Like Skin Inflammation (2025)
International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114064
What this means: This companion study focused specifically on acemannan's mechanism in psoriatic inflammation — particularly its effect on the cytokine environment driving skin hyperproliferation. Psoriasis involves excessive keratinocyte proliferation driven by dysregulated immune signaling. Acemannan's ability to modulate the cytokine profile in psoriatic tissue addresses the inflammatory driver rather than just the surface presentation.
Aloe Vera Polysaccharides as Therapeutic Agents: Benefits Versus Side Effects in Biomedical Applications (2025)
MDPI. https://www.mdpi.com/2673-4176/6/2/36
What this means: This broad 2025 review covers acemannan's role in collagen synthesis, fibroblast stimulation, wound healing, and skin barrier restoration. Documents clinical use in psoriasis and eczema formulations. Addresses the side effect profile alongside the therapeutic evidence — a useful resource for weighing benefit against risk in dermatological applications.
Aloe Vera Attenuated Liver Injury in Mice with Acetaminophen-Induced Hepatitis (2014)
BMC Complementary Medicine and Therapies. https://pmc.ncbi.nlm.nih.gov/articles/PMC4227002/
What this means: Acetaminophen-induced hepatotoxicity is a standard model for studying liver injury. This study showed that aloe vera extract significantly reduced liver enzyme elevations (ALT), reduced oxidative stress markers in liver tissue, and improved histological findings. The untreated group showed severe centrilobular hemorrhagic necrosis. The aloe-treated group showed only focal necrosis. Glutathione levels — the liver's primary antioxidant defense — were preserved. Prior animal studies have shown similar hepatoprotection against alcohol, carbon tetrachloride, and other hepatotoxic compounds.
Network Pharmacology and Molecular Docking Study on the Multi-Target Mechanisms of Aloe Vera for Non-Alcoholic Steatohepatitis Treatment (2022)
Plants. 11(24):3585. https://www.mdpi.com/2223-7747/11/24/3585
What this means: This computational study identified aloe vera's potential targets for treating NASH — non-alcoholic steatohepatitis, the progressive form of fatty liver disease. Using network pharmacology and molecular docking, the researchers identified core pathways: AKT1/mTORC1/NF-κB/ROS/TNFα. These are the same inflammation and oxidative stress pathways implicated in NASH progression. The active aloe compounds showed binding affinity to proteins at these pathway nodes.
The Effect of Aloe Vera Juice on Liver Enzymes and Hepatic Structure in a Healthy Population (2020)
PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC7572145
What this means: This study looked at liver safety in people who did not have liver disease — an important baseline. The review confirmed that inner gel acemannan extract is safe per EFSA guidance. Liver toxicity concerns in the literature are specifically linked to whole-leaf aloe products that contain anthraquinones (aloin) — not inner gel extracts. The compound with the liver concerns is not acemannan.
Aloe Vera Ameliorates Hyperlipidemia, Enhances Antioxidant Activity, and Regulates Liver Function in High-Fat Diet Fed Mice (2022)
Journal of Nutrition and Metabolism. https://journals.sagepub.com/doi/abs/10.3233/MNM-220028
What this means: This study examined aloe vera's effects in mice fed a high-fat diet — an obesity and NAFLD model. Liver histology showed normal architecture in the aloe-treated mice versus numerous hepatic vacuoles (fat droplets) in the untreated high-fat group. Aloe treatment regulated liver function enzymes, prevented hyperlipidemia, and increased endogenous antioxidant activity. The hepatic fat accumulation seen in the untreated group is the precursor to NAFLD progression.
Lee D et al. — Polysaccharide Isolated from Aloe Vera Gel Suppresses Ovalbumin-Induced Food Allergy Through Inhibition of Th2 Immunity in Mice (2018)
Biomedicine & Pharmacotherapy. 101:201-210. https://sciencedirect.com/science/article/pii/S0753332217365137
What this means: This study used a standard food allergy animal model and showed that aloe polysaccharides suppressed the Th2 immune response driving allergic symptoms — the pathway that produces IgE antibodies, activates mast cells, and drives histamine release. The aloe group showed significantly reduced histamine levels, reduced mast cell activation markers, reduced IgE, and suppressed Th2 cytokines IL-4, IL-5, and IL-13. Body temperature was maintained and allergic symptoms were attenuated. The mechanism was IL-10 stimulation — the regulatory cytokine documented in the immune modulation research.
Natural Anti-Inflammatory and Anti-Allergy Agents: Herbs and Botanical Ingredients (2022)
PubMed. https://pubmed.ncbi.nlm.nih.gov/35410623/
What this means: This review documents scientific evidence for the anti-histaminic and antiallergic activity of aloe vera, covering both the immune modulation mechanisms and respiratory allergy applications. Useful as a reference that situates aloe vera alongside other botanicals with documented antiallergic activity.
Alprogen — Direct Mast Cell Stabilization
International Journal of Molecular Sciences. 2021. https://www.mdpi.com/1422-0067/22/4/1708
What this means: Alprogen is a glycoprotein found in aloe vera gel that directly blocks calcium influx into mast cells. When a mast cell encounters an allergen-antibody complex, calcium enters the cell and triggers degranulation — the release of histamine, leukotrienes, and other inflammatory mediators. Alprogen interrupts this process at the calcium channel, physically blocking mast cell activation independent of acemannan's immune signaling effects. Both compounds are present in whole inner leaf gel.
Gao Y et al. — Aloe-Emodin as a Highly Potent Mast Cell Stabilizer Through Activating Mitochondrial Calcium Uniporter (2021)
Biochemical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/33607072/
Important caveat: Aloe-emodin is an anthraquinone from the outer leaf, not present in anthraquinone-free acemannan extracts. Included here for completeness — relevant if using whole-leaf products, not inner gel acemannan specifically.
What this means: This study demonstrated that aloe-emodin is a potent mast cell stabilizer working through a different mechanism than alprogen — activating the mitochondrial calcium uniporter. The mast cell stabilization effect is well-documented. The caveat is that this compound is removed in anthraquinone-free inner gel processing, so this mechanism applies to whole-leaf preparations, not pure acemannan extracts.
Acemannan's IL-10 Induction and Mast Cell Regulation
Im SA et al. 2010. https://pubmed.ncbi.nlm.nih.gov/20361311/
What this means: IL-10 is one of the primary regulatory brakes on mast cell overactivation. Acemannan has been shown to increase IL-10, the anti-inflammatory cytokine that directly suppresses mast cell degranulation and histamine release. This gives acemannan a second mechanism relevant to allergy and histamine: not just direct mast cell stabilization via alprogen, but systemic immune regulation through IL-10 that creates an environment less prone to mast cell overreaction.
Jittapiromsak N et al. — Acemannan Stimulates Dental Pulp Cell Proliferation, Differentiation, Mineralization, and Dentin Formation (2010)
Journal of Dentistry. https://pubmed.ncbi.nlm.nih.gov/20088703/
What this means: This study tested acemannan's effects on dental pulp cells — the living tissue inside teeth. Acemannan stimulated those cells to proliferate, differentiate, form mineralized deposits, and produce dentin. Dentin is the hard tissue forming the bulk of each tooth. Acemannan supports the biological machinery responsible for tooth structure and repair, making it clinically relevant for vital pulp therapy — procedures aimed at preserving living tissue inside teeth after injury or decay.
Impact of Acemannan on Dental Pulp Stem Cells and Healing of Mandibular Defects in Rabbits (2024)
PubMed. https://pubmed.ncbi.nlm.nih.gov/38765804/
What this means: This 2024 study examined acemannan's effect on dental pulp stem cells and tested its capacity to support bone and tissue repair in jaw defects in rabbits. Stem cell proliferation and differentiation were enhanced. Defect healing was accelerated. The bone regeneration findings align with the broader acemannan and bone research, confirming that tissue-repair effects extend to mineralized tissue in the jaw.
Poor MR et al. — Reduction in the Incidence of Alveolar Osteitis in Patients Treated with the SaliCept Patch Containing Acemannan Hydrogel (2002)
Journal of Oral and Maxillofacial Surgery. 60:374-379. → Search link
What this means: Alveolar osteitis — dry socket — is a painful complication following tooth extraction where the blood clot dislodges before the socket can heal. This clinical study showed that an acemannan hydrogel patch placed in the extraction socket significantly reduced the incidence of dry socket compared to standard care. The mechanism combines acemannan's wound healing properties with its anti-inflammatory and antimicrobial activity. One of the few clinical dental applications with direct patient outcome data.
Acemannan as a Biological Agent for Guided Bone Regeneration — Systematic Review (2000–2023)
PubMed systematic review search: → Search link
What this means: A systematic review covering 16 eligible studies — 9 experimental studies, 4 clinical trials, and 2 case reports — examining acemannan's role in guided bone regeneration from 2000 to 2023. The accumulated evidence supports acemannan's use as a bioactive scaffold material that stimulates bone-forming cells, promotes mineralization, and supports the structural scaffolding needed for new bone growth. Its anti-inflammatory properties reduce the chronic inflammation that can impair bone repair.
Acemannan Used as Implantable Biomaterial for Vital Pulp Therapy of Immature Permanent Teeth (2020)
Pharmaceutics. 2020. https://pubmed.ncbi.nlm.nih.gov/32650533/
What this means: This study developed and tested acemannan as an implantable biomaterial for vital pulp therapy in immature permanent teeth — a clinical scenario where preserving the living pulp allows the root to continue developing. Acemannan was biocompatible, stimulated dentin bridge formation, and maintained pulp vitality. Biocompatibility is a prerequisite for clinical use — acemannan does not trigger rejection or excessive inflammatory response when implanted.
Note: Several studies in this section are older observational reports and conference presentations not indexed on PubMed. They are included for reference with that caveat clearly noted.
Nisinzwelg R — Glyconutrient Supplementation in Autistic Children (1999)
University of Calgary Academic Archive. → Search link
What this means: This observational report from 1999 documented glyconutrient and phytonutrient supplementation in autistic children, tracking improvements across communication, sensory, behavioral, and functional domains, with reported improvement rates of 71–95%. These are observational findings — they cannot establish causation. Included because they represent early clinical observations that preceded controlled research in this area.
Omelchuk S, Wells D — Glyconutrient Supplementation in Learning-Disabled Children (2004)
Scholar search: → Search link
What this means: This study examined glyconutrient supplementation in learning-disabled children, tracking language, coordination, sensory processing, behavior, and academic performance. Documented improvements were reported across multiple domains. Like the autism observation above, this is an early-stage observational report — useful as context for the research trajectory, not as standalone clinical evidence.
Benton H — Glyconutrient and Phytonutrient Support in Developmental Dyslexia (1997)
Scholar search: → Search link
What this means: An early observational report examining glyconutrient supplementation in children with developmental dyslexia. Included as part of the historical record of pediatric observations in this category.
Yisrael S, Morris R — Micronutrient and Glyconutrient Support in High-Need Student Cohort (2003)
Scholar search: → Search link
What this means: This observational study examined glyconutrient supplementation in a high-need student cohort and reported reduced disciplinary actions, improved attention, and medication discontinuation in a subset of participants. An early-stage report without controlled methodology — included for completeness in the pediatric research category.
Dykman KD, Dykman RA — Effect of Nutritional Supplements on Attentional-Deficit Hyperactivity Disorder (1998)
Integrative Physiological and Behavioral Science. → Search link
What this means: The most formally structured of the pediatric studies listed — published in an indexed journal and available through PubMed. Examined the effect of nutritional supplements including glyconutrients on ADHD symptoms. Documented behavioral and attentional improvements in a subset of children with ADHD. The mechanism was not isolated to acemannan specifically but to the glyconutrient supplement category.
Zesiewiecz T et al. — Glyconutrient Supplementation in Pediatric Bipolar Patterns: Mood Stability and Behavioral Regulation (2003 and 2005)
Scholar search: → Search link
What this means: Two observational reports from 2003 and 2005 examining glyconutrient supplementation in children with bipolar-like behavioral patterns. Documented improvements in mood stability and behavioral regulation. Observational methodology — included as part of the historical pediatric research record.
Stancil AN, Hicks LH — Glyconutrients and Perception, Cognition, and Memory (2009)
Perceptual and Motor Skills. → Search link
What this means: This study examined glyconutrient supplementation and cognitive performance measures including perception, cognition, and memory. The findings supported measurable improvements in cognitive function. Glyconutrients as a category includes acemannan-containing compounds, though not exclusively.
Best T et al. — Twelve-Week Polysaccharide Supplementation Improves Psychological and Physical Well-Being in Adults (2011)
PubMed search: → Search link
What this means: This 12-week supplementation study tracked polysaccharide supplementation in adults and measured psychological and physical well-being outcomes, documenting meaningful improvements across multiple categories. While not acemannan-specific, it contributes to the body of evidence that polysaccharide supplementation produces measurable effects on health measures.
Liu C et al. — Extraction, Purification, Structural Characteristics, Biological Activities and Pharmacological Applications of Acemannan: A Review (2019)
Molecules. 24(8):1554. https://pubmed.ncbi.nlm.nih.gov/31010204/
What this means: This review provides a thorough examination of acemannan's chemistry, extraction methods, structural features, and the full range of documented biological activities. Covers immune modulation, wound healing, antitumor activity, antiviral effects, and the gut. The structural section is particularly valuable — it explains why molecular weight and acetylation degree affect biological activity. A useful starting reference for anyone wanting a single source that maps the breadth of acemannan research.
U.S. Patent 5,106,616 — Pharmaceutical Composition Containing Acemannan
Google Patents. https://patents.google.com/patent/US5106616A
What this means: This patent covers acemannan as a pharmaceutical compound for treating specific conditions. Patents require demonstrating that something works — the patent office evaluates the data. This patent's existence confirms that acemannan was recognized at the regulatory level as having therapeutic activity worth protecting.
U.S. Patent 5,118,673 — Method of Treating Animals with Acemannan
Google Patents. https://patents.google.com/patent/US5118673A
What this means: This patent covers veterinary treatment applications of acemannan — the methods for treating animals — which align with the fibrosarcoma and spontaneous tumor research in the oncology section. The fibrosarcoma trials in dogs and cats were part of the data underlying this patent.
U.S. Patent 4,917,890 — Stabilized Aloe Vera Gel Composition
Google Patents. https://patents.google.com/patent/US4917890A
What this means: Fresh aloe vera gel degrades rapidly. The active acemannan fraction breaks down within hours of processing. This patent covers a stabilization method that preserves acemannan's biological activity through processing. Stabilization technology is critical because unstabilized products may contain little functional acemannan regardless of what the label says.
U.S. Patent 4,735,935 — Aloe Vera Gel Stabilization and Preservation
Google Patents. https://patents.google.com/patent/US4735935A
What this means: This earlier stabilization patent addresses the same fundamental problem — maintaining acemannan's molecular integrity from harvest to consumption. The research into stabilization methods was driven by the observation that raw aloe gel products showed inconsistent biological activity, tracing back to degradation during processing and storage.
USPTO full search (acemannan, acetylated polymannose, Carrington Laboratories): https://ppubs.uspto.gov/pubwebapp/static/pages/ppubsbasic.html
The following search links pull current PubMed results for each topic area. Useful for staying current as new research is published.
Acemannan and macrophage: → Search link
Acemannan and NK cell: → Search link
Acemannan and wound healing: → Search link
Acemannan and fibrosarcoma (veterinary oncology): → Search link
Acemannan and feline immunodeficiency virus: → Search link
Acemannan and HIV antiviral: → Search link
Acemannan and colitis: → Search link
Acemannan and diabetes: → Search link
Acemannan and psoriasis: → Search link
Acemannan and oxidative stress: → Search link
Acemannan and vaccine adjuvant: → Search link
Acemannan and apoptosis/cancer: → Search link
Acemannan and skin wound healing: → Search link
Mannose receptor and macrophage: → Search link
Polysaccharide immune modulation: → Search link
Stem cell proliferation and polysaccharide: → Search link
Hematopoiesis and immune regulation: → Search link
Glutathione and immune regulation: → Search link
Nutrient absorption and immune function: → Search link
Malnutrition and immune recovery: → Search link
Mucosal immunity overview: → Search link
Gut microbiome and immune system: → Search link
Scrimshaw NS / Nutrition + immunity: → Search link
This document does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or health condition. Always consult a qualified healthcare provider before making decisions about your health.
This document was compiled by The Ace Edit founders, Niccole Rae and Brandon J. Perez, for personal research and educational reference purposes only. This document is a curated research reference and reflects original editorial work. It is not intended for redistribution, republication, or use in any commercial or business context without express written permission from the authors.
© The Ace Edit. All rights reserved.